Edwards Lifesciences (EW) FCF Margin (2009 - 2026)

Edwards Lifesciences' FCF Margin history runs 18 years deep, the most recent figure standing at 1.28% for Q1 2026.

• In Q1 2026, FCF Margin fell 1716.0% year-over-year to 1.28%; the TTM figure through Mar 2026 stood at 17.28% (up 582.0% YoY), while the FY2025 annual figure was 22.0%, up 1667.0% from the prior year.
• FCF Margin was 1.28% for Q1 2026 at Edwards Lifesciences, down from 22.52% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 49.76% in Q4 2022 to a low of 12.79% in Q4 2024.
• Historically, FCF Margin has averaged 15.62% across 5 years, with a median of 18.95% in 2022.
• The sharpest annual moves came in 2023 and 2025: FCF Margin tumbled 4594 bps in 2023, then surged 3532 bps in 2025.
• A 5-year view of FCF Margin shows it stood at 49.76% in 2022, then plunged by 92 bps to 3.81% in 2023, then tumbled by 435 bps to 12.79% in 2024, then surged by 276 bps to 22.52% in 2025, then tumbled by 106 bps to 1.28% in 2026.
• The last three FCF Margin figures came in at 1.28% (Q1 2026), 22.52% (Q4 2025), and 33.24% (Q3 2025), per Business Quant data.